Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Kedoya Adyaraya Tbk
RSGK
Sector: Healthcare
Industry: Healthcare Providers
Sub Sector: Healthcare Equipment & Providers
Sub Industry: Healthcare Providers
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
41
ROE
4,46%
ROA
3,55%
Book Value
912
Net Income
18,92 M
Total Sales
261,38 M
Total Assets
1,07 T
DER
0.26x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
5,69%
SARANA MEDITAMA METROPOLITAN TBK PT 🔗
77,31%
Corporate · Lokal
PT. BESTAMA MEDIKACENTER INVESTAMA 🔗
13,13%
Corporate · Lokal
PT. INTIMANUNGGAL MULTI DEVELOPMENT 🔗
2,34%
Corporate · Lokal
PT TRIMEGAH SEKURITAS INDONESIA TBK 🔗
1,53%
Securities Company · Lokal
Tentang Perusahaan
PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.
Produk & Lini Bisnis
The Company scope of activities is healthcare services.
Dewan Direksi
DJ
dr. Juniwati Gunawan
President Director
HM
Hendra Munanto
Director
AA
Armen Antonius Djan
Director
DN
Drg Nailufar, MARS
Director
Dewan Komisaris
JH
Jusup Halimi
President Commissioner
DL
dr Liem Kian Hong
Vice Commissioner
HS
Hungkang Sutedja
Commissioner
DY
dr Yanto Sandy Tjang
Independent Commissioner
MC
Murniadi Chandra
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
Direct Ownership
 %
PT Daya Guna Usaha
Service and Trading on Health
 Jakarta 99.50%
PT Sinar Medika Sejahtera
Healthcare services
 Bekasi 90.00%
PT Sinar Medika Sutera
Healthcare services
 Tangerang 90.00%
Indirect Ownership
 %
PT Sinar Medika Farma
Pharmacy
 Bekasi 90.00%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
470jt 352jt 235jt 117jt 0 Sales 2025Q2: Rp 219.355.918 Net Income 2025Q2: Rp 19.250.014 2025Q2 Sales 2025Q3: Rp 342.061.835 Net Income 2025Q3: Rp 27.710.475 2025Q3 Sales 2025Q4: Rp 469.592.693 Net Income 2025Q4: Rp 34.507.059 2025Q4 Sales 2026Q1: Rp 127.711.905 Net Income 2026Q1: Rp 9.367.805 2026Q1 Sales 2026Q2: Rp 261.382.970 Net Income 2026Q2: Rp 18.915.976 2026Q2
2025 Q2
EPS 41
ROE 4,71%
2025 Q3
EPS 40
ROE 4,48%
2025 Q4
EPS 37
ROE 4,16%
2026 Q1
EPS 40
ROE 4,47%
2026 Q2
EPS 41
ROE 4,46%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 261,38 M 18,92 M 1,07 T 847,78 M 41 4,46% 0.26x
2026 Q1 127,71 M 9,37 M 1,08 T 838,20 M 40 4,47% 0.28x
2025 Q4 469,59 M 34,51 M 1,08 T 828,79 M 37 4,16% 0.31x
2025 Q3 342,06 M 27,71 M 1,08 T 825,49 M 40 4,48% 0.31x
2025 Q2 219,36 M 19,25 M 928,15 M 816,99 M 41 4,71% 0.14x
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 1.005 912 3,55%
2026 1 1.560 902 3,49%
2025 4 980 891 3,18%
2025 3 980 888 3,42%
2025 2 980 879 4,15%
Data diperbarui pada: 2026-05-12 11:49:17